2022 Q3 Form 10-Q Financial Statement

#000165495422011254 Filed on August 15, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $42.64M $62.91M $50.10M
YoY Change 90.74%
Cash & Equivalents $36.24M $46.58M $26.38M
Short-Term Investments $6.405M $16.33M $23.72M
Other Short-Term Assets $12.37M $11.29M $8.828M
YoY Change 1032.36%
Inventory $183.8K $168.4K $135.8K
Prepaid Expenses
Receivables $74.98M $75.07M $68.92M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $130.3M $149.5M $128.1M
YoY Change 64.89%
LONG-TERM ASSETS
Property, Plant & Equipment $1.661M $1.698M $1.854M
YoY Change -41.29%
Goodwill $36.02M $36.02M
YoY Change
Intangibles $10.86M
YoY Change
Long-Term Investments
YoY Change
Other Assets $4.790M $4.811M $7.603M
YoY Change -24.5%
Total Long-Term Assets $57.19M $57.77M $58.46M
YoY Change 144.79%
TOTAL ASSETS
Total Short-Term Assets $130.3M $149.5M $128.1M
Total Long-Term Assets $57.19M $57.77M $58.46M
Total Assets $187.5M $207.3M $186.5M
YoY Change 83.12%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $82.06M $99.75M $89.99M
YoY Change 28.69%
Accrued Expenses $10.00M $8.163M $7.805M
YoY Change 278.81%
Deferred Revenue
YoY Change
Short-Term Debt $2.152M $2.757M $0.00
YoY Change 42.12%
Long-Term Debt Due $134.1K $159.2K $2.860M
YoY Change -95.67%
Total Short-Term Liabilities $116.5M $157.9M $105.9M
YoY Change 63.94%
LONG-TERM LIABILITIES
Long-Term Debt $22.91M $22.39M $29.70M
YoY Change 61.68%
Other Long-Term Liabilities $2.209M $2.552M $2.840M
YoY Change 481.98%
Total Long-Term Liabilities $25.12M $24.94M $32.54M
YoY Change 72.64%
TOTAL LIABILITIES
Total Short-Term Liabilities $116.5M $157.9M $105.9M
Total Long-Term Liabilities $25.12M $24.94M $32.54M
Total Liabilities $141.6M $182.8M $138.4M
YoY Change 65.42%
SHAREHOLDERS EQUITY
Retained Earnings -$161.2M -$175.2M -$128.7M
YoY Change
Common Stock $20.65K $20.61K $17.53M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $16.57M $7.235M $41.26M
YoY Change
Total Liabilities & Shareholders Equity $187.5M $207.3M $186.5M
YoY Change 83.12%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001277250
dei Amendment Flag
AmendmentFlag
false
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
206082652 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
184266934 shares
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
861222 usd
CY2020Q2 us-gaap Debt Instrument Increase Accrued Interest
DebtInstrumentIncreaseAccruedInterest
12125 usd
CY2021Q2 crge Debt Discount
DebtDiscount
0 usd
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
46905000 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-41354
dei Entity Registrant Name
EntityRegistrantName
CHARGE ENTERPRISES, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
90-0471969
dei Entity Address Address Line1
EntityAddressAddressLine1
125 Park Avenue
dei Entity Address Address Line2
EntityAddressAddressLine2
25th Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
New York
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10017
dei City Area Code
CityAreaCode
212
dei Local Phone Number
LocalPhoneNumber
921-2100
dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001
dei Trading Symbol
TradingSymbol
CRGE
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
206157652 shares
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
46581305 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18238264 usd
CY2022Q2 us-gaap Accounts Receivable Net
AccountsReceivableNet
202220 usd
CY2021Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
176949 usd
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
75068872 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
73334183 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
168430 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
111070 usd
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3034526 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1721222 usd
CY2022Q2 us-gaap Marketable Securities
MarketableSecurities
16325152 usd
CY2021Q4 us-gaap Marketable Securities
MarketableSecurities
9618743 usd
CY2022Q2 crge Investment In Non Marketable Securities
InvestmentInNonMarketableSecurities
100000 usd
CY2021Q4 crge Investment In Non Marketable Securities
InvestmentInNonMarketableSecurities
100000 usd
CY2022Q2 us-gaap Costs In Excess Of Billings On Uncompleted Contracts Or Programs
CostsInExcessOfBillingsOnUncompletedContractsOrPrograms
8258082 usd
CY2021Q4 us-gaap Costs In Excess Of Billings On Uncompleted Contracts Or Programs
CostsInExcessOfBillingsOnUncompletedContractsOrPrograms
4812483 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
149536367 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
107935965 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1697810 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2011668 usd
CY2022Q2 us-gaap Intangible Assets Current
IntangibleAssetsCurrent
11063395 usd
CY2021Q4 us-gaap Intangible Assets Current
IntangibleAssetsCurrent
0 usd
CY2022Q2 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
381110 usd
CY2021Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
469645 usd
CY2022Q2 crge Right Of Use Asset
RightOfUseAsset
3800935 usd
CY2021Q4 crge Right Of Use Asset
RightOfUseAsset
1558052 usd
CY2022Q2 crge Asset Noncurrent
AssetNoncurrent
232000 usd
CY2021Q4 crge Asset Noncurrent
AssetNoncurrent
0 usd
CY2022Q2 us-gaap Goodwill
Goodwill
36017209 usd
CY2021Q4 us-gaap Goodwill
Goodwill
26054522 usd
CY2022Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
4579213 usd
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
5579660 usd
CY2022Q2 us-gaap Assets
Assets
207308039 usd
CY2021Q4 us-gaap Assets
Assets
143609512 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
99752963 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
71428301 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8162742 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5739475 usd
CY2022Q2 us-gaap Deferred Revenue
DeferredRevenue
5276074 usd
CY2021Q4 us-gaap Deferred Revenue
DeferredRevenue
7017392 usd
CY2022Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
40442518 usd
CY2021Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
0 usd
CY2022Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
0 usd
CY2021Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
2700337 usd
CY2022Q2 us-gaap Line Of Credit
LineOfCredit
2757218 usd
CY2021Q4 us-gaap Line Of Credit
LineOfCredit
1898143 usd
CY2022Q2 crge Finance Leases Liability
FinanceLeasesLiability
159215 usd
CY2021Q4 crge Finance Leases Liability
FinanceLeasesLiability
159215 usd
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
1325013 usd
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
125191 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
157875743 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
89068054 usd
CY2022Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
134639 usd
CY2021Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
218825 usd
CY2022Q2 crge Operating Lease Liability Non Current
OperatingLeaseLiabilityNonCurrent
2552449 usd
CY2021Q4 crge Operating Lease Liability Non Current
OperatingLeaseLiabilityNonCurrent
1442743 usd
CY2022Q2 us-gaap Notes Payable
NotesPayable
22253430 usd
CY2021Q4 us-gaap Notes Payable
NotesPayable
26087523 usd
CY2022Q2 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
0 usd
CY2021Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
4475260 usd
CY2022Q2 us-gaap Liabilities
Liabilities
182816261 usd
CY2021Q4 us-gaap Liabilities
Liabilities
121292405 usd
CY2022Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
17256656 usd
CY2021Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
6850000 usd
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
206082652 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
184266934 shares
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
20608 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
18426 usd
CY2022Q2 crge Common Stock To Be Issued
CommonStockToBeIssued
0 shares
CY2021Q4 crge Common Stock To Be Issued
CommonStockToBeIssued
6587897 shares
CY2022Q2 crge Common Stock To Be Issued Shares
CommonStockToBeIssuedShares
0 usd
CY2021Q4 crge Common Stock To Be Issued Shares
CommonStockToBeIssuedShares
658 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
182479967 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
126869604 usd
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Before Tax1
AccumulatedOtherComprehensiveIncomeLossBeforeTax1
-32859 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Before Tax1
AccumulatedOtherComprehensiveIncomeLossBeforeTax1
-32289 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-175232712 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-111389529 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
7235122 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
15467107 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
207308039 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
143609512 usd
CY2022Q2 us-gaap Revenues
Revenues
181040612 usd
CY2021Q2 us-gaap Revenues
Revenues
129576795 usd
us-gaap Revenues
Revenues
344018502 usd
us-gaap Revenues
Revenues
240710698 usd
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
173759629 usd
CY2021Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
127425665 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
330267261 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
236985532 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
7280983 usd
CY2021Q2 us-gaap Gross Profit
GrossProfit
2151130 usd
us-gaap Gross Profit
GrossProfit
13751241 usd
us-gaap Gross Profit
GrossProfit
3725166 usd
CY2022Q2 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
9760707 usd
CY2021Q2 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
9230400 usd
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
20504339 usd
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
13793596 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3907831 usd
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2140701 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6904515 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3395701 usd
CY2022Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
4127328 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-19642252 usd
CY2021Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
1791076 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
8370009 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
2623460 usd
CY2022Q2 us-gaap Professional Fees
ProfessionalFees
848122 usd
CY2021Q2 us-gaap Professional Fees
ProfessionalFees
585449 usd
us-gaap Professional Fees
ProfessionalFees
1912609 usd
us-gaap Professional Fees
ProfessionalFees
832601 usd
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1103065 usd
CY2021Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
97956 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1312119 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
147903 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
19747053 usd
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
13845582 usd
us-gaap Operating Expenses
OperatingExpenses
39003591 usd
us-gaap Operating Expenses
OperatingExpenses
20793261 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-12466070 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-11694452 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-25252350 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-17068095 usd
CY2022Q2 us-gaap Net Investment Income
NetInvestmentIncome
-912369 usd
CY2021Q2 us-gaap Net Investment Income
NetInvestmentIncome
859614 usd
us-gaap Net Investment Income
NetInvestmentIncome
-1022375 usd
us-gaap Net Investment Income
NetInvestmentIncome
4261328 usd
CY2022Q2 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
6414071 usd
CY2021Q2 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
920914 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
7443668 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
982788 usd
CY2022Q2 crge Amortization Of Debt Discount Related Party
AmortizationOfDebtDiscountRelatedParty
0 usd
CY2021Q2 crge Amortization Of Debt Discount Related Party
AmortizationOfDebtDiscountRelatedParty
0 usd
crge Amortization Of Debt Discount Related Party
AmortizationOfDebtDiscountRelatedParty
0 usd
crge Amortization Of Debt Discount Related Party
AmortizationOfDebtDiscountRelatedParty
95127 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
745728 usd
CY2021Q2 us-gaap Interest Expense
InterestExpense
267681 usd
us-gaap Interest Expense
InterestExpense
1480781 usd
us-gaap Interest Expense
InterestExpense
448683 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
715238 usd
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-10508 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
913591 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-10838 usd
CY2022Q2 crge Foreign Exchange Adjustments
ForeignExchangeAdjustments
169411 usd
CY2021Q2 crge Foreign Exchange Adjustments
ForeignExchangeAdjustments
-61234 usd
crge Foreign Exchange Adjustments
ForeignExchangeAdjustments
-86191 usd
crge Foreign Exchange Adjustments
ForeignExchangeAdjustments
-512712 usd
CY2022Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-7187519 usd
CY2021Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-400723 usd
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-9119424 usd
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
2211180 usd
CY2022Q2 us-gaap Income Loss From Subsidiaries Tax Expense Benefit
IncomeLossFromSubsidiariesTaxExpenseBenefit
19653589 usd
CY2021Q2 us-gaap Income Loss From Subsidiaries Tax Expense Benefit
IncomeLossFromSubsidiariesTaxExpenseBenefit
12095175 usd
us-gaap Income Loss From Subsidiaries Tax Expense Benefit
IncomeLossFromSubsidiariesTaxExpenseBenefit
34371774 usd
us-gaap Income Loss From Subsidiaries Tax Expense Benefit
IncomeLossFromSubsidiariesTaxExpenseBenefit
14856915 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11337 usd
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2010198 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1589620 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3192832 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-10084977 usd
us-gaap Net Income Loss
NetIncomeLoss
-32782154 usd
us-gaap Net Income Loss
NetIncomeLoss
-11664083 usd
CY2022Q2 crge Deemed Dividend
DeemedDividend
-32841317 usd
CY2021Q2 crge Deemed Dividend
DeemedDividend
0 usd
crge Deemed Dividend
DeemedDividend
-36697317 usd
crge Deemed Dividend
DeemedDividend
0 usd
CY2022Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
352826 usd
CY2021Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
0 usd
us-gaap Dividends Preferred Stock
DividendsPreferredStock
619813 usd
us-gaap Dividends Preferred Stock
DividendsPreferredStock
0 usd
CY2022Q2 crge Net Income Loss Available To Common Stockholders
NetIncomeLossAvailableToCommonStockholders
-52836395 usd
CY2021Q2 crge Net Income Loss Available To Common Stockholders
NetIncomeLossAvailableToCommonStockholders
-10084977 usd
crge Net Income Loss Available To Common Stockholders
NetIncomeLossAvailableToCommonStockholders
-70099284 usd
crge Net Income Loss Available To Common Stockholders
NetIncomeLossAvailableToCommonStockholders
-11664083 usd
CY2022Q2 crge Basic And Diluted Loss Per Share Available To Common Stockholders
BasicAndDilutedLossPerShareAvailableToCommonStockholders
-0.27
CY2021Q2 crge Basic And Diluted Loss Per Share Available To Common Stockholders
BasicAndDilutedLossPerShareAvailableToCommonStockholders
-0.07
crge Basic And Diluted Loss Per Share Available To Common Stockholders
BasicAndDilutedLossPerShareAvailableToCommonStockholders
-0.37
crge Basic And Diluted Loss Per Share Available To Common Stockholders
BasicAndDilutedLossPerShareAvailableToCommonStockholders
-0.08
CY2022Q2 crge Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
193507946 shares
CY2021Q2 crge Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
151120416 shares
crge Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
190965948 shares
crge Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
149463702 shares
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-19642252 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-10084977 usd
us-gaap Net Income Loss
NetIncomeLoss
-32782154 usd
us-gaap Net Income Loss
NetIncomeLoss
-11664083 usd
CY2022Q2 us-gaap Temporary Equity Foreign Currency Translation Adjustments
TemporaryEquityForeignCurrencyTranslationAdjustments
-675 usd
CY2021Q2 us-gaap Temporary Equity Foreign Currency Translation Adjustments
TemporaryEquityForeignCurrencyTranslationAdjustments
-62630 usd
us-gaap Temporary Equity Foreign Currency Translation Adjustments
TemporaryEquityForeignCurrencyTranslationAdjustments
-570 usd
us-gaap Temporary Equity Foreign Currency Translation Adjustments
TemporaryEquityForeignCurrencyTranslationAdjustments
-82086 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-675 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-62630 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-570 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-82086 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-19642927 usd
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10147607 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-32782724 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-11746169 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
15467107 usd
CY2022Q1 crge Stock Based Compensation Expense Amount
StockBasedCompensationExpenseAmount
10743632 usd
CY2022Q1 crge Declaration Of Preferred Dividends
DeclarationOfPreferredDividends
-266984 usd
CY2022Q1 crge Series C Preferred Stock Member Amount
SeriesCPreferredStockMemberAmount
12050000 usd
CY2022Q1 crge Beneficial Conversion Feature Arising From Preferred Stock Amount
BeneficialConversionFeatureArisingFromPreferredStockAmount
2651000 usd
CY2022Q1 crge Deemed Dividend In Connection With Series C Preferred Stock Amount
DeemedDividendInConnectionWithSeriesCPreferredStockAmount
-3856000 usd
CY2022Q1 crge Common Stock Issued For Acquisition Amount
CommonStockIssuedForAcquisitionAmount
17530278 usd
CY2022Q1 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
79990 usd
CY2022Q1 crge Net Loss
NetLoss
-13139797 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
41259226 usd
CY2022Q2 crge Stock Based Compensation Expense Amount
StockBasedCompensationExpenseAmount
9342734 usd
CY2022Q2 crge Declaration Of Preferred Dividends
DeclarationOfPreferredDividends
-352827 usd
CY2022Q2 crge Series D Preferred Stock Shares
SeriesDPreferredStockShares
12498889 shares
CY2022Q2 crge Common Stock Issued For Private Placement Amount
CommonStockIssuedForPrivatePlacementAmount
4695864 usd
CY2022Q2 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
5304161 usd
CY2022Q2 crge Issuance Of Shares Committed In Prior Period Amount
IssuanceOfSharesCommittedInPriorPeriodAmount
0 usd
CY2022Q2 crge Settlement Of Holdback Shares For Acquisition Shares
SettlementOfHoldbackSharesForAcquisitionShares
1 shares
CY2022Q2 crge Exercise Of Warrants Amount
ExerciseOfWarrantsAmount
1072424 usd
CY2022Q2 crge Exercise Of Stock Options Amount
ExerciseOfStockOptionsAmount
20000 usd
CY2022Q2 crge Exercise Of Restricted Stock Units Amount
ExerciseOfRestrictedStockUnitsAmount
14 usd
CY2022Q2 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
6165000 usd
CY2022Q2 crge Classification Of Preferred C To Mezzanine Equity Amount
ClassificationOfPreferredCToMezzanineEquityAmount
-12684917 usd
CY2022Q2 crge Deemed Dividend In Connection With Reclass Of Warrants To Derivative Liability
DeemedDividendInConnectionWithReclassOfWarrantsToDerivativeLiability
-40442518 usd
CY2022Q2 crge Stock Issued During Period Amount Other
StockIssuedDuringPeriodAmountOther
-1 usd
CY2022Q2 crge Net Loss
NetLoss
-19642927 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
7235122 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
20653095 usd
CY2021Q1 crge Shares Of Common Stock From Prior Year Issued Amount
SharesOfCommonStockFromPriorYearIssuedAmount
0 usd
CY2021Q1 crge Common Stock Issued For Services Amount
CommonStockIssuedForServicesAmount
167348 usd
CY2021Q1 crge Conversion Of Debt And Accrued Interest Amount
ConversionOfDebtAndAccruedInterestAmount
1010650 usd
CY2021Q1 crge Stock Based Compensation Expense Amount
StockBasedCompensationExpenseAmount
4563197 usd
CY2021Q1 crge Adjustment To Par Value
AdjustmentToParValue
0 usd
CY2021Q1 crge Net Loss
NetLoss
-1598563 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
24795727 usd
CY2021Q2 crge Shares Of Common Stock From Prior Period Issued Amount
SharesOfCommonStockFromPriorPeriodIssuedAmount
0 usd
CY2021Q2 crge Common Stock Issued For Services Amount
CommonStockIssuedForServicesAmount
111555 usd
CY2021Q2 crge Stock Based Compensation Expense Amount
StockBasedCompensationExpenseAmount
9230399 usd
CY2021Q2 us-gaap Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
2654300 usd
CY2021Q2 crge Derivative Liability Reclassed To Equity
DerivativeLiabilityReclassedToEquity
750000 usd
CY2021Q2 crge Net Loss
NetLoss
-10147607 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
27394374 usd
us-gaap Net Income Loss
NetIncomeLoss
-32782154 usd
us-gaap Net Income Loss
NetIncomeLoss
-11664083 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1312119 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
147903 usd
us-gaap Share Based Compensation
ShareBasedCompensation
20086367 usd
us-gaap Share Based Compensation
ShareBasedCompensation
13819067 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
0 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
278903 usd
us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
0 usd
us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
400 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
7443668 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
982788 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
0 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
95127 usd
crge Amortization Of Debts Issue Costs
AmortizationOfDebtsIssueCosts
0 usd
crge Amortization Of Debts Issue Costs
AmortizationOfDebtsIssueCosts
10438 usd
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-86191 usd
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-533663 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
-1022375 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
4261328 usd
crge Other Operating Income Expense Net1
OtherOperatingIncomeExpenseNet1
854850 usd
crge Other Operating Income Expense Net1
OtherOperatingIncomeExpenseNet1
0 usd
crge Income Tax Benefit Expense
IncomeTaxBenefitExpense
-1589620 usd
crge Income Tax Benefit Expense
IncomeTaxBenefitExpense
-3195383 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1733639 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-5630739 usd
crge Increase Decrease In Accrued Revenue
IncreaseDecreaseInAccruedRevenue
3842574 usd
crge Increase Decrease In Accrued Revenue
IncreaseDecreaseInAccruedRevenue
-654303 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
57360 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
25759 usd
us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
304368 usd
us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
-2317539 usd
crge Increase Decrease In Other Assets
IncreaseDecreaseInOtherAssets
29538 usd
crge Increase Decrease In Other Assets
IncreaseDecreaseInOtherAssets
103260 usd
crge Costs In Excess Of Billings
CostsInExcessOfBillings
-7288173 usd
crge Costs In Excess Of Billings
CostsInExcessOfBillings
0 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
27162062 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3031568 usd
crge Increase Decrease In Accrued Expenses
IncreaseDecreaseInAccruedExpenses
1235985 usd
crge Increase Decrease In Accrued Expenses
IncreaseDecreaseInAccruedExpenses
482204 usd
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-173601 usd
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
0 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-1741320 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
0 usd
us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-571 usd
us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-82086 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
15636147 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1281000 usd
crge Payment To Acquire Fixed Assets
PaymentToAcquireFixedAssets
70542 usd
crge Payment To Acquire Fixed Assets
PaymentToAcquireFixedAssets
801254 usd
crge Sale Of Intellectual Property
SaleOfIntellectualProperty
159434 usd
crge Sale Of Intellectual Property
SaleOfIntellectualProperty
0 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
43255509 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
42529309 usd
crge Proceeds From Sale Of Marketable Securities
ProceedsFromSaleOfMarketableSecurities
34901415 usd
crge Proceeds From Sale Of Marketable Securities
ProceedsFromSaleOfMarketableSecurities
39731309 usd
crge Payments To Acquire Non Marketable Securities
PaymentsToAcquireNonMarketableSecurities
0 usd
crge Payments To Acquire Non Marketable Securities
PaymentsToAcquireNonMarketableSecurities
100000 usd
crge Acquisition Of Ans
AcquisitionOfAns
0 usd
crge Acquisition Of Ans
AcquisitionOfAns
12948324 usd
crge Acquisition Of Ev Depot
AcquisitionOfEvDepot
1231250 usd
crge Acquisition Of Ev Depot
AcquisitionOfEvDepot
0 usd
us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
104485 usd
us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
40940 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9391967 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-16606638 usd
us-gaap Proceeds From Issuance Of Medium Term Notes
ProceedsFromIssuanceOfMediumTermNotes
0 usd
us-gaap Proceeds From Issuance Of Medium Term Notes
ProceedsFromIssuanceOfMediumTermNotes
10000000 usd
crge Proceeds From Convertible Notes Payable
ProceedsFromConvertibleNotesPayable
0 usd
crge Proceeds From Convertible Notes Payable
ProceedsFromConvertibleNotesPayable
5000000 usd
crge Proceeds From Sale Of Common Stock
ProceedsFromSaleOfCommonStock
-10000025 usd
crge Proceeds From Sale Of Common Stock
ProceedsFromSaleOfCommonStock
0 usd
crge Proceeds From Sale Of Series C Preferred Stock
ProceedsFromSaleOfSeriesCPreferredStock
-10845000 usd
crge Proceeds From Sale Of Series C Preferred Stock
ProceedsFromSaleOfSeriesCPreferredStock
0 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1072424 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
20000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
crge Draws From Revolving Line Of Credit Net
DrawsFromRevolvingLineOfCreditNet
859075 usd
crge Draws From Revolving Line Of Credit Net
DrawsFromRevolvingLineOfCreditNet
-703650 usd
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
0 usd
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
61232 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
102295 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
7525 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
498598 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
22195631 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
14227593 usd
crge Foreign Currency Adjustment
ForeignCurrencyAdjustment
-96770 usd
crge Foreign Currency Adjustment
ForeignCurrencyAdjustment
-485222 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
28343041 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1583267 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18238264 usd
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11629303 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
46581305 usd
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10046036 usd
us-gaap Interest Paid Net
InterestPaidNet
1476842 usd
us-gaap Interest Paid Net
InterestPaidNet
247900 usd
crge Issuance Of Series B Preferred Stock For Acquisition
IssuanceOfSeriesBPreferredStockForAcquisition
0 usd
crge Issuance Of Series B Preferred Stock For Acquisition
IssuanceOfSeriesBPreferredStockForAcquisition
6850000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
17530278 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
crge Debt Discount Associated With Promissory Notes
DebtDiscountAssociatedWithPromissoryNotes
0 usd
crge Debt Discount Associated With Promissory Notes
DebtDiscountAssociatedWithPromissoryNotes
4296911 usd
us-gaap Nature Of Operations
NatureOfOperations
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 1 Nature of operations</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Charge Enterprises, Inc., through its subsidiaries (sometimes referred to herein as “we,” “us,” “our,” “Charge” or the “Company”) consists of a portfolio of global businesses with a vision to build the electrification and telecommunications infrastructure that will address and service requirements for EVC (“Electrical Vehicle Charging”) and WNI (“Wireless Network Infrastructure”) which includes 5G, tower, distributed antennae systems (“DAS”), small cell, and electrical infrastructure.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company operates in two segments: Telecommunications, which provides connection of voice calls, data and Short Message Services (SMS) to global carriers and Infrastructure which builds physical wireless network elements, provides electrical construction services and installs and maintains EV charging stations and infrastructure. Financial information about each business segment is contained in Note 14 Reportable segments.</p>
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 integer
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
9408550 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
9372253 usd
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7710740 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7360584 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1697810 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2011668 usd
CY2022Q2 us-gaap Depreciation
Depreciation
241843 usd
us-gaap Depreciation
Depreciation
450897 usd
CY2021Q2 us-gaap Depreciation
Depreciation
97956 usd
us-gaap Depreciation
Depreciation
147903 usd
CY2022Q2 us-gaap Marketable Securities
MarketableSecurities
16325152 usd
CY2021Q4 us-gaap Marketable Securities
MarketableSecurities
9618743 usd
us-gaap Dilutive Securities
DilutiveSecurities
18289580 usd
CY2021 us-gaap Dilutive Securities
DilutiveSecurities
10549524 usd
CY2021 us-gaap Unrealized Gain On Securities
UnrealizedGainOnSecurities
0 usd
us-gaap Unrealized Gain On Securities
UnrealizedGainOnSecurities
0 usd
us-gaap Unrealized Loss On Securities
UnrealizedLossOnSecurities
1964428 usd
CY2021 us-gaap Unrealized Loss On Securities
UnrealizedLossOnSecurities
930781 usd
crge Fair Value Of Assets
FairValueOfAssets
16325152 usd
CY2021 crge Fair Value Of Assets
FairValueOfAssets
9618743 usd
CY2022Q2 crge Net Gains Within Net Income From Investments On Statement Of Operations
NetGainsWithinNetIncomeFromInvestmentsOnStatementOfOperations
912369 usd
crge Net Gains Within Net Income From Investments On Statement Of Operations
NetGainsWithinNetIncomeFromInvestmentsOnStatementOfOperations
1022375 usd
CY2022Q2 crge Realized Gains Loss
RealizedGainsLoss
-205554 usd
crge Realized Gains Loss
RealizedGainsLoss
301419 usd
CY2022Q2 crge Unrealized Losses
UnrealizedLosses
706815 usd
crge Unrealized Losses
UnrealizedLosses
1323794 usd
CY2022Q1 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
1231250 usd
CY2022Q1 us-gaap Accrued Liabilities Fair Value Disclosure
AccruedLiabilitiesFairValueDisclosure
18750 usd
CY2022Q1 us-gaap Asset Acquisition Contingent Consideration Liability
AssetAcquisitionContingentConsiderationLiability
6827 usd
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
17530278 usd
CY2022Q1 us-gaap Business Combination Consideration Transferred1
BusinessCombinationConsiderationTransferred1
18787105 usd
CY2022Q2 us-gaap Finite Lived Customer Relationships Gross
FiniteLivedCustomerRelationshipsGross
11924617 usd
CY2022Q2 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
3026788 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
861222 usd
us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
6019 usd
CY2022Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
12498889 usd
CY2022Q2 crge Discounted Convertible Notes
DiscountedConvertibleNotes
8205504 usd
CY2022Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
249978 usd
CY2022Q2 crge Amortization Of Debt Discount1
AmortizationOfDebtDiscount1
4845236 usd
CY2022Q2 crge Accumulated Amortization Deferred Finance Costs1
AccumulatedAmortizationDeferredFinanceCosts1
0 usd
crge Amortization Of Debt Discount
AmortizationOfDebtDiscount
95127 usd
CY2022Q2 crge Paycheck Protection Program Loan
PaycheckProtectionProgramLoan
0 usd
CY2021Q4 crge Paycheck Protection Program Loan
PaycheckProtectionProgramLoan
2000000 usd
CY2021Q4 crge Notes Payable Issued
NotesPayableIssued
11860055 usd
CY2022Q2 crge Notes Payable Issued
NotesPayableIssued
11860055 usd
CY2021Q4 crge Notes Payable Issued December
NotesPayableIssuedDecember
15925926 usd
CY2022Q2 crge Notes Payable Issued December
NotesPayableIssuedDecember
15925926 usd
CY2022Q2 crge Unamortized Discount And Debt Issue Cost
UnamortizedDiscountAndDebtIssueCost
-5532551 usd
CY2021Q4 crge Unamortized Discount And Debt Issue Cost
UnamortizedDiscountAndDebtIssueCost
-3698458 usd
CY2022Q2 us-gaap Notes Payable
NotesPayable
22253430 usd
CY2021Q4 us-gaap Notes Payable
NotesPayable
26087523 usd
CY2022Q2 crge Reimburse Sba Loan
ReimburseSBALoan
2000000 usd
CY2022Q2 crge Loan Reclassified
LoanReclassified
2000000 usd
CY2022Q2 crge Paycheck Protection Program Loans
PaycheckProtectionProgramLoans
2000000 usd
crge Interest Expense And Amortisation Debt Discount
InterestExpenseAndAmortisationDebtDiscount
<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Three Months Ended June 30,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Six Months Ended June 30,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Interest Expense </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">484,639</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">969,278</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Amortization of debt discount</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,568,835</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">2,052,644</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Total </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">2,053,474</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">3,021,922</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2022Q2 us-gaap Interest Expense Other
InterestExpenseOther
484639 usd
us-gaap Interest Expense Other
InterestExpenseOther
0 usd
us-gaap Interest Expense Other
InterestExpenseOther
969278 usd
CY2021Q2 us-gaap Interest Expense Other
InterestExpenseOther
0 usd
CY2022Q2 crge Amortization Of Debt Discount And Financing Costs
AmortizationOfDebtDiscountAndFinancingCosts
1568835 usd
CY2021Q2 crge Amortization Of Debt Discount And Financing Costs
AmortizationOfDebtDiscountAndFinancingCosts
0 usd
crge Amortization Of Debt Discount And Financing Costs
AmortizationOfDebtDiscountAndFinancingCosts
2052644 usd
crge Debt Discount
DebtDiscount
0 usd
CY2022Q2 crge Debt Discount
DebtDiscount
2053474 usd
crge Amortization Of Debt Discount And Financing Costs
AmortizationOfDebtDiscountAndFinancingCosts
0 usd
crge Debt Discount
DebtDiscount
3021922 usd
CY2022Q2 crge Accrued Interest Notes
AccruedInterestNotes
0 usd
CY2021Q4 crge Accrued Interest Notes
AccruedInterestNotes
115250 usd
CY2022Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
40400000 usd
crge Derivative Deemed Dividend
DerivativeDeemedDividend
32800000 usd
CY2021Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
0 usd
CY2020Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
749600 usd
crge Reclassification Of Derivative
ReclassificationOfDerivative
40442518 usd
crge Reclassification Of Derivative
ReclassificationOfDerivative
-749200 usd
crge Change In Fair Value Of Derivative Liabilities
ChangeInFairValueOfDerivativeLiabilities
0 usd
crge Change In Fair Value Of Derivative Liabilities
ChangeInFairValueOfDerivativeLiabilities
-400 usd
CY2022Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
40442518 usd
CY2021Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
0 usd
CY2022Q2 us-gaap Sales Type Lease Revenue
SalesTypeLeaseRevenue
1300000 usd
us-gaap Sales Type Lease Revenue
SalesTypeLeaseRevenue
2400000 usd
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1103065 usd
CY2021Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
97956 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1312119 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
147903 usd
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q2 crge Outstanding Warrants To Purchase Common Stock
OutstandingWarrantsToPurchaseCommonStock
11800000 shares
CY2022Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
40400000 usd
crge Deemed Dividend Amount
DeemedDividendAmount
32800000 usd
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
44920000 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.78
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2550000 shares
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.47
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
565000 shares
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
3.16
CY2022Q1 crge Options Outstanding Ending Balance
OptionsOutstandingEndingBalance
46905000 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.85
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
14737501 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.14
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
3475000 shares
CY2022Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
5.00
CY2022Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
10000 shares
CY2022Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.00
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
687500 shares
CY2022Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
2.99
CY2022Q2 crge Options Outstanding Ending Balance
OptionsOutstandingEndingBalance
49682500 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.69
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
18361001 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.47
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P4Y9M29D
crge Unrecognized Costs Related To Stock Options Granted
UnrecognizedCostsRelatedToStockOptionsGranted
39245445 usd
CY2022Q2 us-gaap Time Deposits At Or Above Fdic Insurance Limit
TimeDepositsAtOrAboveFDICInsuranceLimit
250000 usd
CY2022Q2 us-gaap Time Deposit Liability Above Us Insurance Limit
TimeDepositLiabilityAboveUsInsuranceLimit
44516287 usd
CY2021Q4 us-gaap Time Deposit Liability Above Us Insurance Limit
TimeDepositLiabilityAboveUsInsuranceLimit
17503737 usd
CY2022Q2 crge Income Loss Before Income Tax Benefit
IncomeLossBeforeIncomeTaxBenefit
-19653589 usd
CY2021Q2 crge Income Loss Before Income Tax Benefit
IncomeLossBeforeIncomeTaxBenefit
-12095175 usd
crge Income Loss Before Income Tax Benefit
IncomeLossBeforeIncomeTaxBenefit
-34371774 usd
crge Income Loss Before Income Tax Benefit
IncomeLossBeforeIncomeTaxBenefit
-14856915 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11337 usd
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2010198 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1589620 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3192832 usd
CY2022Q2 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.001 pure
CY2021Q2 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.166 pure
us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.046 pure
us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.215 pure

Files In Submission

Name View Source Status
0001654954-22-011254-index-headers.html Edgar Link pending
0001654954-22-011254-index.html Edgar Link pending
0001654954-22-011254.txt Edgar Link pending
0001654954-22-011254-xbrl.zip Edgar Link pending
crge-20220630.xsd Edgar Link pending
crge_10q.htm Edgar Link pending
crge_ex311.htm Edgar Link pending
crge_ex312.htm Edgar Link pending
crge_ex321.htm Edgar Link pending
crge_ex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
crge-20220630_cal.xml Edgar Link unprocessable
crge-20220630_lab.xml Edgar Link unprocessable
crge-20220630_pre.xml Edgar Link unprocessable
crge_10q_htm.xml Edgar Link completed
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
crge-20220630_def.xml Edgar Link unprocessable